OIS has a strong antitumor role, which has been shown in various benign lesions such as nevus, neurofibroma, and schwannoma, and is accompanied by overexpression of p16 and cell cycle arrest [35,36,37,38,39,40]. This evidence concerns the gene CDKN2A and neurofibroma.